Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04255160
PHASE4

Impact of Estradiol on Endothelial Function in Peri-Menopausal Women

Sponsor: University of Delaware

View on ClinicalTrials.gov

Summary

The purpose of this study is to identify the impact of estradiol (E2) on the mechanisms that regulate vascular endothelial function in peri-menopausal (PERI) women. This study is the first step in understanding factors contributing to endothelial dysfunction in women with advancing reproductive age and in response to E2 administration.

Key Details

Gender

FEMALE

Age Range

40 Years - 58 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2020-10-01

Completion Date

2026-06-30

Last Updated

2026-02-03

Healthy Volunteers

Yes

Interventions

DRUG

Estradiol (mylan or vivelle dot patch)

Transdermal estradiol (0.1mg/day patch) will be used by women for 7 days. Administration of the patch will follow the package guidelines to change the patch after 3-4 days of use.

OTHER

Placebo

A placebo patch that is visually similar to the estradiol patch will be used for the group not receiving estradiol.

Locations (1)

University of Delaware

Newark, Delaware, United States